CN Bio and Altis Biosystems Partner to Develop Next-generation Human Gut/Liver in vitro model for Advanced ADME Studies

CAMBRIDGE, England, & DURHAM, N.C--(BUSINESS WIRE)--CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership. Through this partnership, Altis’ human RepliGut® Planar-Jejunum model will be integrated with CN Bio’s PhysioMimix® Liver-on-a-Chip to create a primary human microphysiological system (MPS), with inter-organ communication to mimic the oral drug adm